Excited to announce that our CEO & President, Pei-Jiun Chen, Ph.D will be speaking at the upcoming Merck Upstream CLD Expert Community－Biosimilar & Cell Line Development Forum in Tokyo!

As next-generation biologics become increasingly complex, developing and manufacturing them presents unique challenges. At Mycenax, we address these hurdles through an integrated cell line development platform combined with intensified fed-batch upstream processing.

【Session Topic】
Advancing Cell Line Development and Intensified Upstream Processing for Next-Generation Biologics

Key Highlights:
- First-hand experience and data demonstrating the potential of Merck's next-generation CHOZN® Elite host cell line.
- How Mycenax utilizes an intensified fed-batch approach with N-1 perfusion to significantly improve production efficiency, shorten timelines, and enhance volumetric productivity—all while ensuring robust product quality and scalability.

Date: October 23, 2026
Venue: Merck Ltd. M Lab™ Collaboration Center (Tokyo)

Register here

We look forward to connecting with industry peers and discussing the future of biosimilar and cell line development!